Sosman JA - Search Results

1

Leptomeningeal metastases: the future is now.

Lukas RV, Thakkar JP, Cristofanilli M, Chandra S, Sosman JA, Patel JD, Kumthekar P, Stupp R, Lesniak MS. Lukas RV, et al. Among authors: sosman ja. J Neurooncol. 2022 Feb;156(3):443-452. doi: 10.1007/s11060-021-03924-2. Epub 2022 Jan 20. J Neurooncol. 2022. PMID: 35048267 Review.

2

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials.

Costa R, Carneiro BA, Agulnik M, Rademaker AW, Pai SG, Villaflor VM, Cristofanilli M, Sosman JA, Giles FJ. Costa R, et al. Among authors: sosman ja. Oncotarget. 2017 Jan 31;8(5):8910-8920. doi: 10.18632/oncotarget.13315. Oncotarget. 2017. PMID: 27852042 Free PMC article. Review.

3

Novel Targeted Therapies for Metastatic Melanoma.

Iams WT, Sosman JA, Chandra S. Iams WT, et al. Among authors: sosman ja. Cancer J. 2017 Jan-Feb;23(1):54-58. doi: 10.1097/PPO.0000000000000242. Cancer J. 2017. PMID: 28114255 Review.

4

Emerging growth factor receptor antagonists for the treatment of advanced melanoma.

Fenton SE, Sosman JA, Chandra S. Fenton SE, et al. Among authors: sosman ja. Expert Opin Emerg Drugs. 2017 Jun;22(2):165-174. doi: 10.1080/14728214.2017.1336537. Expert Opin Emerg Drugs. 2017. PMID: 28562096 Review.

5

Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.

Zhai L, Ladomersky E, Lauing KL, Wu M, Genet M, Gritsina G, Győrffy B, Brastianos PK, Binder DC, Sosman JA, Giles FJ, James CD, Horbinski C, Stupp R, Wainwright DA. Zhai L, et al. Among authors: sosman ja. Clin Cancer Res. 2017 Nov 1;23(21):6650-6660. doi: 10.1158/1078-0432.CCR-17-0120. Epub 2017 Jul 27. Clin Cancer Res. 2017. PMID: 28751450 Free PMC article.

6

Melanoma: What do all the mutations mean?

Davis EJ, Johnson DB, Sosman JA, Chandra S. Davis EJ, et al. Among authors: sosman ja. Cancer. 2018 Sep 1;124(17):3490-3499. doi: 10.1002/cncr.31345. Epub 2018 Apr 17. Cancer. 2018. PMID: 29663336 Free PMC article. Review.

7

Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma.

Cavalcante L, Chowdhary A, Sosman JA, Chandra S. Cavalcante L, et al. Among authors: sosman ja. Am J Clin Dermatol. 2018 Oct;19(5):657-670. doi: 10.1007/s40257-018-0359-4. Am J Clin Dermatol. 2018. PMID: 29961183 Review.

8

Immune Checkpoint Inhibitor Toxicity in 2018.

Johnson DB, Chandra S, Sosman JA. Johnson DB, et al. Among authors: sosman ja. JAMA. 2018 Oct 23;320(16):1702-1703. doi: 10.1001/jama.2018.13995. JAMA. 2018. PMID: 30286224 No abstract available.

9

Adverse Events Associated With Immune Checkpoint Inhibitors-Reply.

Johnson DB, Chandra S, Sosman JA. Johnson DB, et al. Among authors: sosman ja. JAMA. 2019 Mar 26;321(12):1219-1220. doi: 10.1001/jama.2018.22123. JAMA. 2019. PMID: 30912830 No abstract available.

10

The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma.

Ladomersky E, Scholtens DM, Kocherginsky M, Hibler EA, Bartom ET, Otto-Meyer S, Zhai L, Lauing KL, Choi J, Sosman JA, Wu JD, Zhang B, Lukas RV, Wainwright DA. Ladomersky E, et al. Among authors: sosman ja. Front Pharmacol. 2019 Mar 27;10:200. doi: 10.3389/fphar.2019.00200. eCollection 2019. Front Pharmacol. 2019. PMID: 30971917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page